Where does Affiris AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Affiris AG ranks #14,434 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Affiris AG hold?

Affiris AG holds 20 US utility patents granted between 2015 and 2021, spanning 6 technology areas.

What is Affiris AG's Innovation Score?

Affiris AG has an Innovation Score of 27.9 out of 100 (25th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Affiris AG focus on?

Affiris AG's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 18 patents, ranking #1,084 of 6,058 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Affiris AG's patent grant rate increasing or decreasing?

Affiris AG's recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Affiris AG's patents?

Affiris AG's patents average 14.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Affiris AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Affiris AG

USPTO PatentsView assignee record - 20 granted patents across 6 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Affiris ranks #14,434 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 6 technology areas.

#14,434
of 49,997 US assignees by volume: 25th percentile
by Innovation Score (27.9/100): 14.4
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14434 · Foreign Corporation #14,434 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,434/49,997
PHOTO-FINISH A J Antunes &
CPC-NARROW A61P · 6 areas
INNOV-THIN 27.9/100
CLAIMS-RICH 14.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: A. J. Antunes & Co. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Affiris’s 27.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (38%) Velocity 0.0 pts (0%) Breadth 8.7 pts (31%) Claim depth 8.7 pts (31%)

Qualcomm Incorporated · highest

85
Affiris · this assignee

28
3D Lighting… · lowest

7

What this shows Affiris's Innovation Score is 27.9/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Affiris?

Each dot is one of Affiris’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Affiris’s own 14.4 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Affiris vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Affiris's grants concentrate

Affiris AG is a focused PatentsView assignee: 6 CPC subclasses with 90% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2016. By volume, Affiris sits between A. J. Antunes & Co. and Airties Kablosuz Iletisim Sanayi VE DIS Ticaret A.S..

A J Antunes &

20
Adlens

20
Advanced Wireless…

20
Aetna Group S P A

20
AFI Licensing

20
Afilias

20
AGT International

20
Airties Kablosuz…

20
Affiris ◀

20

What this shows Affiris holds 20 patents at rank #14,421, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Affiris

By rank, the assignees closest to #14,421 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Affiris's primary technology class.

Affiris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Affiris AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	15.0%
2016	1	5.0%
2017	4	20.0%
2018	4	20.0%
2019	4	20.0%
2020	2	10.0%
2021	2	10.0%

Which technologies does Affiris AG patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 18

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 17

C07K - Peptides 12

C12Y - Enzymes 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Affiris AG's patent record in context - here's where to go next.

Affiris AG's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #14,434 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Affiris AG against A. J. Antunes & Co., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.